{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:06:19Z","timestamp":1784307979552,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bulcan.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:54:41Z","timestamp":1779216881000},"page":"828-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9tat des lieux des pratiques et de la prise en charge du syndrome g\u00e9nito-urinaire des patientes trait\u00e9es pour un cancer du sein"],"prefix":"10.1016","volume":"113","author":[{"given":"Am\u00e9lie","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fiteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bulcan.2026.03.010_bib0190","doi-asserted-by":"crossref","first-page":"e000562","DOI":"10.1136\/esmoopen-2019-000562","article-title":"UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)","volume":"4","author":"Ines","year":"2019","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.010_bib0195","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3949\/ccjm.85a.17108","article-title":"Genito-urinary syndrome of menopause in breast cancer survivors: treatments are available","volume":"85","author":"Moreno","year":"2018","journal-title":"Cleveland Clin J Med"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.010_bib0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13697137.2017.1421921","article-title":"The writing group of the GENISSE study. Genito-urinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study","volume":"21","author":"Moral","year":"2018","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.010_bib0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal health: insights, views & attitudes (VIVA)\u00a0\u2013\u00a0results from an international survey","volume":"15","author":"Nappi","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0210","doi-asserted-by":"crossref","DOI":"10.61622\/rbgo\/2025rbgo46","article-title":"Vaginal estrogen therapy for treatment of menopausal genitourinary syndrome among breast cancer survivors: a systematic review and meta-analysis","volume":"47","author":"Santos","year":"2025","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2018.07.003","article-title":"Survivorship issues as determinants of quality of life after breast cancer treatment: report from a limited resource setting","volume":"41","author":"Kaur","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2020.08.010","article-title":"Genito-urinary syndrome of menopause: current treatment options in breast cancer survivors\u00a0\u2013\u00a0systematic review","volume":"143","author":"Mension","year":"2021","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.010_bib0225","first-page":"131","article-title":"Management of genitourinary symptoms in patients with breast cancer: an updated systematic review of available evidence from randomized trials","volume":"31","author":"Fallah","year":"2023","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.bulcan.2026.03.010_bib0230","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JOP.18.00710","article-title":"Managing genito-urinary syndrome of menopause in breast cancer survivors receiving endocrine therapy","volume":"15","author":"Sussman Tamara","year":"2019","journal-title":"J Oncol Pract"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.010_bib0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/GME.0000000000001279","article-title":"Can the use of probiotics in association with isoflavone improve the symptoms of genitourinary syndrome of menopause? Results from a randomized controlled trial","volume":"26","author":"Ribeiro","year":"2018","journal-title":"Menopause"},{"issue":"10430","key":"10.1016\/j.bulcan.2026.03.010_bib0240","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.010_bib0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11912-024-01633-3","article-title":"Effectiveness of pelvic floor muscle and education-based therapies on bladder, bowel, vaginal, sexual, psychological function, quality of life, and pelvic floor muscle function in females treated for breast cancer: a systematic review","volume":"27","author":"Cyr","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0250","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/IJWH.S414509","article-title":"Genito-urinary syndrome of menopause in breast cancer survivors: current perspectives on the role of laser therapy","volume":"15","author":"Cucinella","year":"2023","journal-title":"Int J Women Health"},{"issue":"14","key":"10.1016\/j.bulcan.2026.03.010_bib0255","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of fractional carbon dioxide laser vs. Sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial","volume":"326","author":"Li","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.010_bib0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1471-0528.17335","article-title":"Laser versus sham for genitourinary syndrome of menopause: a randomised controlled trial","volume":"130","author":"Page","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0265","article-title":"Efficacy and safety of fractional microablative radiofrequency versus topical estriol in treating genitourinary syndrome of menopause: a pilot study","author":"Torre","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.010_bib0270","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bulcan.2023.03.018","article-title":"Photobiomodulation et troubles vulvovaginaux apr\u00e8s traitements anticanc\u00e9reux [photobiomodulation and vulvovaginal disorders after anticancer treatments]","volume":"110","author":"Forret","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0275","doi-asserted-by":"crossref","first-page":"108264","DOI":"10.1016\/j.maturitas.2025.108264","article-title":"Hyaluronic acid injection to treat symptoms of vulvovaginal atrophy in postmenopausal women: a 12-week randomised, placebo-controlled, multicentric study","volume":"197","author":"Marchand Lamiraud","year":"2025","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.010_bib0280","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1089\/jwh.2023.0144","article-title":"Comparable efficacy of submucosal platelet-rich plasma and combined platelet-rich plasma noncrosslinked hyaluronic acid injections in vulvovaginal atrophy: a cancer survivorship issue","volume":"32","author":"Omar","year":"2023","journal-title":"J Womens Health"},{"issue":"13","key":"10.1016\/j.bulcan.2026.03.010_bib0285","first-page":"7420","article-title":"A new treatment of genito-urinary post-menopausal atrophy with autologous micro-fragmented fat tissue: a thirty-six months follow up case series","volume":"24","author":"Casarotti","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2023.10.028","article-title":"Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review","volume":"291","author":"Parenti","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.010_bib0295","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genito-urinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.010_bib0300","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.010_bib0305","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40266-019-00700-w","article-title":"Practical treatment considerations in the management of genito-urinary syndrome of menopause","volume":"36","author":"Risa","year":"2019","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.010_bib0310","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bulcan.2023.08.014","article-title":"Genito-urinary syndrome of menopause in patients with breast cancer treated by hormonotherapy: women's perception in ITAC, a French web-based survey","volume":"111","author":"Mar\u00e8s","year":"2024","journal-title":"Bull Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.010_bib0315","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11764-017-0606-3","article-title":"A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy","volume":"11","author":"Advani","year":"2017","journal-title":"J Cancer Surviv"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.010_bib0320","first-page":"394","article-title":"Syndrome g\u00e9nito-urinaire de la m\u00e9nopause (SGUM). RPC les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi [genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]","volume":"49","author":"Hock\u00e9","year":"2021","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.010_bib0325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-024-07564-8","article-title":"Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial","volume":"210","author":"Faltinova","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.010_bib0330","doi-asserted-by":"crossref","first-page":"262e1","DOI":"10.1016\/j.ajog.2024.10.054","article-title":"Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks","volume":"232","author":"Beste","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.010_bib0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.010_bib0340","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jnci\/djac112","article-title":"Systemic or vaginal hormone therapy after early breast cancer: a danish observational cohort study","volume":"114","author":"Cold","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.010_bib0345","doi-asserted-by":"crossref","first-page":"e0330156","DOI":"10.1371\/journal.pone.0330156","article-title":"Effectiveness of radiofrequency and exercise-based rehabilitation on symptoms associated with pelvic floor dysfunction in breast cancer patients: a study protocol","volume":"20","author":"Salar-Andreu","year":"2025","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.010_bib0350","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":"Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2022.08.013","article-title":"Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: a randomized controlled trial","volume":"167","author":"Gold","year":"2023","journal-title":"Maturitas"},{"key":"10.1016\/j.bulcan.2026.03.010_bib0360","article-title":"Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: a systematic review of randomized controlled trial","author":"Serquiz","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.010_bib0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/lsm.70027","article-title":"Efficacy of erbium and CO2\u00a0genital laser treatment on genito-urinary syndrome in female patients after breast cancer: a scoping review","volume":"57","author":"Ferreira","year":"2025","journal-title":"Lasers Surg Med"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.010_bib0185","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/AOG.0000000000006081","article-title":"Platelet-Rich Plasma for Genito-urinary Syndrome of Menopause in Breast Cancer Survivors","volume":"146","author":"Chen","year":"2025","journal-title":"Obstet Gynecol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:29:46Z","timestamp":1784305786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126002274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0007455126002274"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tat des lieux des pratiques et de la prise en charge du syndrome g\u00e9nito-urinaire des patientes trait\u00e9es pour un cancer du sein","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}